Connect with us

CNBC

Biden to announce Merck will help make Johnson & Johnson’s Covid vaccine

Biden will announce Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson’s Covid-19 vaccine, a senior administration official said.

Published

on

President Joe Biden will announce Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson‘s Covid-19 vaccine, a senior administration official confirmed to NBC News.

The decision comes as the administration works to ramp up production of J&J’s single-shot vaccine. Senior administration officials said Sunday the U.S. government would ship J&J’s entire inventory of 3.9 million doses this week, adding that supply would be “uneven” in the following weeks. Some 16 million more doses are expected by the end of the month.

Under the arrangement, Merck will dedicate two facilities in the U.S. to J&J’s vaccine, according to NBC. One will make the vaccine and the other will provide “fill-finish” services, when the vaccine is placed in vials.

Officials began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that J&J had fallen behind in vaccine production, according to NBC. They soon sought a deal with Merck, which scrapped plans to develop its own Covid vaccine in January after a clinical trial showed its shots were ineffective.

J&J declined to comment to CNBC on the deal. In a statement, Merck said it “remains steadfast in our commitment to contribute to the global response to the pandemic and to preparing to address future pandemics.”

Biden is expected to make the announcement from the White House on Tuesday afternoon.

The Food and Drug Administration on Saturday authorized J&J’s vaccine for use in people 18 and older. Unlike Pfizer‘s and Moderna‘s vaccines, J&J’s one-dose regimen eliminates the need for patients to return for a second dose, and it can be stored at refrigerator temperatures for months.

By comparison, Pfizer’s vaccine needs to be stored in ultracold freezers that keep it between minus 112 and minus 76 degrees Fahrenheit, though the FDA recently allowed the company to store its vaccine for two weeks at temperatures commonly found in pharmaceutical freezers. Moderna’s vaccine needs to be shipped at 13 below to 5 degrees above zero Fahrenheit.

The New York Times first reported in January that unexpected manufacturing delays would lead to a reduced initial supply of J&J’s drug if it were given emergency authorization.

White House Chief Medical Advisor Dr. Anthony Fauci said last month he was “disappointed” with the number of doses initially expected from J&J, adding the federal government thought there would be “considerably more.” The New Jersey-based company has a deal with the U.S. to provide 100 million doses by the end of June.

“It may take until June, July and August to finally get everybody vaccinated,” Fauci told CNN on Feb. 16. “So when you hear about how long it’s going to take to get the overwhelming proportion of the population vaccinated, I don’t think anybody disagrees that that’s going to be well to the end of the summer and we get into the early fall.”

At the time, Biden’s Covid czar, Jeff Zients, said the federal government was doing “everything we can working with the company to accelerate the delivery schedule.”

This isn’t the first partnership between two drugmakers to help ramp up the vaccine supply.

In late January, French drugmaker Sanofi announced it would help fill and pack millions of doses of Pfizer’s two-shot vaccine in an effort to help meet demand. Moderna has a partnership with Swiss company Lonza, which produces most of the drug substances for the company’s vaccine.

The Biden administration has also said it is using the Defense Production Act to help ramp up supply of Pfizer’s vaccine.

Officials began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that J&J had fallen behind in vaccine production, according to NBC. They soon sought a deal with Merck, which scrapped plans to develop its own Covid vaccine in January after a clinical trial showed its shots were ineffective.

Source: https://www.cnbc.com/2021/03/02/covid-vaccine-biden-to-announce-merck-will-help-make-johnson-johnsons-shot.html

biden-to-announce-merck-will-help-make-johnson-&-johnson's-covid-vaccine

CNBC

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/earnings/

earnings

Continue Reading

CNBC

International: Top News And Analysis

CNBC International is the world leader for news on business, technology, China, trade, oil prices, the Middle East and markets.

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/us-top-news-and-analysis/

international:-top-news-and-analysis

Continue Reading

CNBC

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/earnings/

earnings

Continue Reading

Title

Crunchbase14 hours ago

Square Rolls Up Afterpay As BNPL Market Stays Hot

Payments platform Square plans to buy Afterpay, an Australian buy now, pay later service, in an all-stock deal valued at...

Bioengineer20 hours ago

$1 million grant to address cold storage logistics in vaccine delivery

Credit: Penn State College of Engineering COVID-19 vaccines have been tested, validated and administered to millions of people around the

Cointelegraph4 days ago

The future of DeFi is spread across multiple blockchains

Creating interoperability, not competition: Multichain solutions will positively impact the blockchain space in terms of accessibility, innovation and economic viability.

Ventureburn4 days ago

ZwartTech launches Talent Foundation to equip Africans with digital skills

Lagos-based ZwartTech has announced the launch of its new edtech, Zwart Talent Foundation (ZTF) in a statement on 30 July...

CNBC6 days ago

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

Bioengineer7 days ago

Reduced microbial stability linked to soil carbon loss in active layer under alpine permafrost degra

Credit: NIEER Chinese researchers have recently discovered links between reduction in microbial stability and soil carbon loss in the active

Reuters1 week ago

Chipmaker TSMC says too early to say on Germany expansion

Taiwan Semiconductor Manufacturing Co Ltd (TSMC) (2330.TW) said on Monday that it was too early to say whether it will...

Bioengineer1 week ago

SNMMI Image of the Year: PET imaging measures cognitive impairment in COVID-19 patients

Credit: G Blazhenets et al., Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of

Techcrunch1 week ago

The DL on CockroachDB – TechCrunch

As college students at Berkeley, Spencer Kimball and Peter Mattis created a successful open-source graphics program, GIMP, which got the...

CNBC1 week ago

International: Top News And Analysis

CNBC International is the world leader for news on business, technology, China, trade, oil prices, the Middle East and markets.

Review

    Select language

    Trending